SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-22-000366
Filing Date
2022-03-04
Accepted
2022-03-04 07:00:27
Documents
15
Period of Report
2022-03-04
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3562_8-k.htm   iXBRL 8-K 36671
2 EXHIBIT 10.1 e3562_10-1.htm EX-10.1 17618
3 EXHIBIT 16.1 e3562_ex16-1.htm EX-16.1 2786
4 EXHIBIT 99.1 e3562_ex99-1.htm EX-99.1 8707
  Complete submission text file 0001731122-22-000366.txt   249764

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE avxl-20220304.xsd EX-101.SCH 3027
6 XBRL LABEL FILE avxl-20220304_lab.xml EX-101.LAB 34476
7 XBRL PRESENTATION FILE avxl-20220304_pre.xml EX-101.PRE 22591
9 EXTRACTED XBRL INSTANCE DOCUMENT e3562_8-k_htm.xml XML 3605
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 22712064
SIC: 2836 Biological Products, (No Diagnostic Substances)